Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
All articles
Showing 1–12 of 411 articles
- Understand the science
How Cells Make Amyloid Beta From a Larger Protein
The catalog name A4 Amyloid Beta does not specify which fragment or physical form is present. That matters because a 40-amino-acid peptide, a 42-amino-acid peptide, and a clump of those peptides are different experimental materials.
A4 Amyloid Beta2 sources (2026)
- Explore study findings
Why Amyloid Beta Fibrils Can Have Different Shapes
Amyloid beta is a family of peptides cut from amyloid precursor protein. Some forms can assemble into long fibers, called fibrils, in which many copies of the peptide align. A label such as A4 Amyloid Beta leaves both the sequence and whether the peptide is already assembled unspecified.
A4 Amyloid Beta1 source (2026)
- Explore study findings
What Amyloid Beta Ratios in Blood Can Reveal Before a Scan Changes
The amyloid beta family includes Aβ42 and Aβ40, two products of the same precursor that differ in length. The ratio of those two forms in plasma is a measurement of circulating peptides. An amyloid PET scan, by contrast, measures a tracer signal associated with deposited amyloid in the brain.
A4 Amyloid Beta2 sources (2026)
- Understand the science
How Small Amyloid Beta Clusters Help Aggregation Spread
Amyloid beta 42, or Aβ42, can be studied as a single chain, as part of a small cluster called an oligomer, or as part of a long fibril. Those states can coexist and change during an experiment.
A4 Amyloid Beta2 sources (2026)
- Explore study findings
What Donanemab Follow Up Teaches About Targeting Amyloid Beta
Amyloid beta is a family of peptides produced from a larger membrane protein. Some forms build up in deposits called plaques. Donanemab is an antibody that targets a form of amyloid beta in those deposits. It is the intervention in the research described here; amyloid beta is the target.
A4 Amyloid Beta1 source (2025)
- Explore study findings
What a Rare APP Mutation Reveals About Amyloid in Brain Blood Vessels
Amyloid beta is cut from amyloid precursor protein, or APP, so a change in the gene for APP can change the peptide itself. A rare inherited variant called the Flemish mutation changes position 21 in Aβ from alanine to glycine.
A4 Amyloid Beta1 source (2026)
- Check methods and identity
What the 2026 marmoset study measured
ACE-031 is a larger engineered fusion protein. It joins the outer, signal-binding part of human activin receptor type IIB to the Fc region of a human antibody.
ACE-0312 sources (2016, 2026)
- Understand the science
How an activin receptor becomes a decoy
ACE-031 uses molecular recognition on the scale of a fusion protein, pairing the signal-binding portion of activin receptor type IIB with an antibody Fc region. Its design raises a specific question about interception. Which signals might a free-floating copy of part of the receptor capture?
ACE-0312 sources (2010, 2026)
- Interpret the evidence
Why the Duchenne trial ended early
ACE-031 is an investigational fusion protein that captures myostatin and related signaling proteins through a soluble piece of activin receptor type IIB. An older human study, first published online in 2016, asked how boys with Duchenne muscular dystrophy tolerated that approach.
ACE-0312 sources (2016, 2026)
- Explore study findings
What changed on scans of healthy volunteers
ACE-031 is a larger investigational fusion protein that binds myostatin and other signals involved in regulating muscle. An older first-in-human study in healthy postmenopausal volunteers provides a direct look at the body composition changes that first drew attention to the molecule.
ACE-0311 source (2012)
- Explore study findings
Did ACE-031 change muscle fiber type or size?
ACE-031 is a fusion protein built from part of activin receptor type IIB and an antibody Fc region. Its ability to capture several growth regulators led researchers to ask whether it changes the kinds of fibers in a muscle or primarily changes their size.
ACE-0312 sources (2010, 2026)
- Check methods and identity
How laboratories tested the identity of products labeled ACE-031
Authentic ACE-031 is a larger fusion protein consisting of a portion of the activin receptor type IIB and a human IgG1 Fc region. An analytical study published in May 2025, before the recent research window, asked whether products sold under that name contained the expected fusion protein.
ACE-0311 source (2025)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
